N(6)-Methyladenosine in Cancer Immunotherapy: An Undervalued Therapeutic Target

N(6)-methylation of adenosine (m(6)A), a post-transcriptional regulatory mechanism, is the most abundant nucleotide modification in almost all types of RNAs. The biological function of m(6)A in regulating the expression of oncogenes or tumor suppressor genes has been widely investigated in various c...

Descripción completa

Detalles Bibliográficos
Autores principales: Quan, Chao, Belaydi, Othmane, Hu, Jiao, Li, Huihuang, Yu, Anze, Liu, Peihua, Yi, Zhenglin, Qiu, Dongxu, Ren, Wenbiao, Ma, Hongzhi, Gong, Guanghui, Ou, Zhenyu, Chen, Minfeng, Sun, Yin, Chen, Jinbo, Zu, Xiongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436617/
https://www.ncbi.nlm.nih.gov/pubmed/34526985
http://dx.doi.org/10.3389/fimmu.2021.697026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436617/
https://www.ncbi.nlm.nih.gov/pubmed/34526985
http://dx.doi.org/10.3389/fimmu.2021.697026

Ejemplares similares